GSK-LSD1 2HCl 25mg | ≥98%
CSNpharm
GSK-LSD1 2HCl
Search Results
GSK-LSD1 2HCl 1mg | ≥98%
CSNpharm
GSK-LSD1 2HCl
FPH2 100mg | ≥99%
CSNpharm
FPH2 is a small molecule, which promotes differentiation of iPS-derived hepatocytes.
More Information Supplier PageFPH2
FPH2 50mg | ≥99%
CSNpharm
FPH2 is a small molecule, which promotes differentiation of iPS-derived hepatocytes.
More Information Supplier PageFPH2
FPH2 10mg | ≥99%
CSNpharm
FPH2 is a small molecule, which promotes differentiation of iPS-derived hepatocytes.
More Information Supplier PageFPH2
FPH2 25mg | ≥99%
CSNpharm
FPH2 is a small molecule, which promotes differentiation of iPS-derived hepatocytes.
More Information Supplier PageFPH2
FPH2 5mg | ≥99%
CSNpharm
FPH2 is a small molecule, which promotes differentiation of iPS-derived hepatocytes.
More Information Supplier PageFPH2
CX-6258 HCl 25mg | ≥98%
CSNpharm
CX-6258 HCl is a potent, orally efficacious pan-Pim kinase inhibitor with IC50 of 5 nM, 25 nM and 16 nM for Pim1, Pim2, and Pim3, respectively.
More Information Supplier PageCX-6258 HCl
CX-6258 HCl 10mg | ≥98%
CSNpharm
CX-6258 HCl is a potent, orally efficacious pan-Pim kinase inhibitor with IC50 of 5 nM, 25 nM and 16 nM for Pim1, Pim2, and Pim3, respectively.
More Information Supplier PageCX-6258 HCl
GSK-J4 HCl 10mg | ≥99%
CSNpharm
GSK-J4 HCl is selective inhibitor of jumonji H3K27 demethylase. It can attenuate lipopolysaccharide (LPS)-induced proinflammatory cytokine production.
More Information Supplier PageGSK-J4 HCl
